VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
Tarih
2008Yazar
Ulutin, T.
Saip, S.
Ozgon, G. Oner
Siva, A.
Buyru, N.
Langaee, T. Y.
feng, h
Johnson, J. A.
Hatemi, A. C.
Üst veri
Tüm öğe kaydını gösterÖzet
Objectives The objective of this study was to determine the quantitative influence of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP 2C9) polymorphisms on warfarin dose requirements in Turkish patients.
Koleksiyonlar
- Makale [92796]